Détermination de la toxicité aigüe cumulée chez le rat - Administration répétée par inhalation pendant 5 jours
€24.00
Détermination de la toxicité aigüe cumulée chez le lapin - Administration percutanée répétée pendant 5 jours
Produits chimiques - Détermination de l'activité mutagène vis-à-vis de {salmonella} {typhimurium} (test d'âmes)
€56.50
Produits chimiques - Évaluation de la toxicité subaiguë chez le lapin - Administration percutanée répétée pendant 28 jours
Joint implants - Part 2: Tiered toolkit approach to evaluate the biological impact of wear particles from joint replacements and related devices
€163.00
Clinical investigation of medical devices for human subjects - Good clinical practice (ISO 14155:2011)
€50.00
Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for snap frozen tissue - Part 3: Isolated DNA
Medical devices utilizing animal tissues and their derivatives - Part 1: Application of risk management (ISO 22442-1:2007)
Requirements for the collection and transport of samples for medical laboratory examinations
In vitro diagnostic Next Generation Sequencing (NGS) workflows - Part 2: Human RNA examination
€184.00
In vitro diagnostic Next Generation Sequencing (NGS) workflows - Part 1: Human DNA examination
Biological evaluation of medical devices - Part 10: Tests for irritation and skin sensitization (ISO 10993-10:2010)
Biorisk management for laboratories and other related organisations — Amendment 1: Climate action changes
This product is not for sale, please contact us for more information
Medical laboratories - Reduction of error through risk management and continual improvement (ISO/TS 22367:2008, including Cor 1:2009)
Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:2010)
